USA Mutuals Advisors’s Syneron Medical Ltd ELOS Stock Holding History

USA Mutuals Advisors’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-166	Closed	-$2K	–	184
2015 Q2	$2K	Buy	+166	New	+$1.94K	﹤0.01%	126

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

USA Mutuals Advisors's ELOS Position: Q3 2015 in Review

USA Mutuals Advisors sold out of Syneron Medical Ltd (ELOS) in Q3 2015, closing a stake of 166 shares — an estimated $2K sold.

USA Mutuals Advisors first reported a position in ELOS in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 66 funds tracked by Wall St. Rank hold ELOS as of Q3 2015.

USA Mutuals Advisors reported no remaining Syneron Medical Ltd position as of Q3 2015 after selling out during the quarter.
USA Mutuals Advisors sold 166 Syneron Medical Ltd shares in Q3 2015, an estimated $2K.
USA Mutuals Advisors first reported a position in Syneron Medical Ltd in Q2 2015 and held it in 1 quarter.
USA Mutuals Advisors's Syneron Medical Ltd position peaked at $2K in Q2 2015.
66 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2015.

Based on USA Mutuals Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.